HLA-DR and SSC were also useful to distinguish between the t(15;17) AML blasts and those from the MLL AML group, followed by FSC, CD11b, CD13, CD64, and CD117 (Figure 5). The gene discussed is KMT2A; the disease is acute myeloid leukemia.